[–] maxharris 6y ago ↗ That report came from a leak that has been misinterpreted, says Gilead: https://www.cnbc.com/2020/04/23/gilead-says-draft-of-coronav...
[–] booosh 6y ago ↗ this is from an RCT. This data is way more powerful than compassionate use data, those are so noisy that are almost impossible to see any signal.
[–] LorenPechtel 6y ago ↗ Amazing how drugs don't do so well when subjected to a proper trial. [–] foobarbazetc 6y ago ↗ First rule of medicine: there’s never a silver bulletThat said, I personally know doctors here in the Bay Area who were part of the remedsivir trial and it does seem to genuinely help in very specific cases. [–] HarryHirsch 6y ago ↗ 2 out of 3 candidates fail in Phase II. We wish we could predict which ones succeed, and still we can't. It's a complete mystery.
[–] foobarbazetc 6y ago ↗ First rule of medicine: there’s never a silver bulletThat said, I personally know doctors here in the Bay Area who were part of the remedsivir trial and it does seem to genuinely help in very specific cases.
[–] HarryHirsch 6y ago ↗ 2 out of 3 candidates fail in Phase II. We wish we could predict which ones succeed, and still we can't. It's a complete mystery.
[–] somid3 6y ago ↗ It is bizarre the study was out of China and was temporarily posted on the WHO’s website.
6 comments
[ 3.1 ms ] story [ 21.9 ms ] threadThat said, I personally know doctors here in the Bay Area who were part of the remedsivir trial and it does seem to genuinely help in very specific cases.